89bio Inc.

NASDAQ: ETNB · Real-Time Price · USD
9.22
0.12 (1.32%)
At close: Aug 15, 2025, 3:59 PM
9.23
0.05%
After-hours: Aug 15, 2025, 04:10 PM EDT

89bio Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
21K 21K 21K 234K 234K 234K 234K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
47K 51K 50K 45K 47K 87K 133K 172K 222K 277K 240K 206K 169K 82K 79K 58K 35K 15K
Gross Profit
-26K -30K -29K -45K -47K -87K -133K -172K -222K -277K -240K -206K -169K -82K -79K -58K -35K -15K
Operating Income
-465.68M -403.29M -384.66M -303.86M -191.26M -179.96M -94.16M -27.59M -15.28M 2.11M -51.52M -103.13M -104.3M -100.11M -89.74M -76.05M -62.27M -53.39M
Interest Income
16.57M 23.04M 23.56M 24.16M 24.31M 22.47M 17.68M 11.97M 7.17M 2.65M 891K 891K 118K n/a n/a n/a n/a n/a
Pretax Income
-448.86M -385.94M -366.39M -284.66M -170.51M -161.07M -138.32M -126.54M -118.62M -105.28M -102.01M -103.86M -105.38M -101.05M -90.27M -76.5M -62.75M -53.8M
Net Income
-450.21M -386.67M -367.08M -288.96M -174.61M -165.03M -197.47M -181.84M -173.92M -160.9M -102.34M -104.03M -105.55M -100.91M -90.12M -76.42M -62.69M -53.74M
Selling & General & Admin
44.64M 41.27M 39.6M 36.49M 33.92M 32.58M 28.96M 27.66M 24.57M 22.41M 21.45M 20.42M 20.2M 20.06M 19.41M 17.93M 16.53M 14.84M
Research & Development
421.04M 362M 345.04M 267.33M 157.3M 147.35M 122.23M 107.7M 98.48M 83.25M 80.8M 82.71M 84.1M 80.05M 70.33M 58.12M 45.74M 38.55M
Other Expenses
-9K -9K -9K n/a n/a n/a n/a n/a 238K 238K 238K 44K -311K -483K -526K -448K -331K -257K
Operating Expenses
465.67M 403.27M 384.63M 303.82M 191.23M 179.93M 151.19M 135.36M 123.06M 105.67M 102.25M 103.13M 104.3M 100.11M 89.74M 76.05M 62.27M 53.39M
Interest Expense
3.42M 3.16M 5.29M 4.96M 3.56M 3.58M 4.79M 3.93M 3.5M 3.04M 1.43M 1.43M 890K 456K n/a n/a n/a n/a
Selling & Marketing Expenses
n/a -12K -21K -37K -37K -25K -16K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
465.72M 403.33M 384.7M 303.86M 191.26M 179.96M 151.2M 135.36M 123.06M 105.67M 102.25M 103.13M 104.3M 100.11M 89.74M 76.05M 62.27M 53.39M
Income Tax Expense
1.08M 458K 692K 4.3M 4.09M 3.95M 59.14M 55.29M 55.3M 55.62M 335K 172K 147K -169K -185K -120K -73K -73K
Shares Outstanding (Basic)
157.88M 115.96M 115.96M 107.08M 99.83M 95.85M 80.7M 76.34M 74.13M 53.17M 50.81M 47.25M 20.35M 20.34M 20.26M 20.09M 20.06M 20.01M
Shares Outstanding (Diluted)
157.88M 115.96M 115.96M 107.08M 99.83M 95.85M 80.7M 76.34M 74.13M 53.17M 50.81M 47.25M 20.35M 20.34M 20.26M 20.09M 20.06M 20.01M
EPS (Basic)
-3.61 -3.38 -3.43 -2.91 -1.97 -2.01 -3.05 -3.03 -3.15 -3.88 -3.56 -4.38 -5.22 -5 -4.48 -3.81 -3.27 -3.09
EPS (Diluted)
-3.61 -3.38 -3.43 -2.91 -1.97 -2.01 -3.05 -3.03 -3.15 -3.88 -3.56 -4.38 -5.22 -5 -4.48 -3.81 -3.27 -3.09
EBITDA
-455.13M -386.26M -361.06M -279.65M -166.91M -157.4M -133.4M -122.44M -115.43M -102.72M -101.1M -102.79M -104.24M -100.03M -89.66M -75.98M -62.2M -53.33M
EBIT
-445.43M -382.78M -361.1M -279.69M -166.95M -157.49M -133.53M -122.61M -115.65M -102.77M -101.12M -102.77M -104.18M -100.11M -89.74M -76.05M -62.27M -53.39M
Depreciation & Amortization
-3.48M -3.48M 38K 45K 47K 87K 133K 172K 222K 277K 240K 206K 169K 82K 79K 71K 66K 63K